Cite Filings / GRI
Feed Companies Filings Check
Sign in

CIK 0001824293 · <br>Emerging growth company

GRI Bio, Inc.

Sign in to watch
Ticker
GRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
824369909
Phone
(619) 400-1171
Business address
2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA, CA, 92037
Former names
Vallon Pharmaceuticals, Inc.
Filings Insiders Search text
All 403 Financials 126 Shareholder Meetings 16 Executive Compensation 119 Insider Trading 69 Beneficial Ownership Interest 35 Business Combinations 112 Public Offerings 114 Mutual Funds and ETFs 10 Others 44
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-09-28
  3. DEF 14A Proxy Proxy Statement 2025-12-29
  4. DEF 14A Proxy Proxy Statement 2025-07-11
  5. DEF 14A Proxy Proxy Statement 2025-01-17
  6. DEF 14A Proxy Proxy Statement 2024-08-02
  7. DEF 14A Proxy Proxy Statement 2024-05-09
  8. DEF 14A Proxy Proxy Statement 2024-01-02
  9. DEF 14A Proxy Proxy Statement 2023-05-26
  10. DEF 14A Proxy Proxy Statement 2022-06-06
  11. DEF 14A Proxy Proxy Statement 2022-04-27

Page 1 of 1 · 10 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…